2nd Quarter - Report — TODD STRATEGY GROUP for GENENTECH, INC. (2021)

Firm

TODD STRATEGY GROUP

Client

GENENTECH, INC.

Income

$60,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare and Medicaid payment issues. Home infusion. 340B issues.

Lobbyist	Covered position, as disclosed
PAUL EDATTEL	Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
DANIEL M TODD	Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Amin Ctr. Medicare & Medicaid

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

COVID-19 Response.

Lobbyist	Covered position, as disclosed
PAUL EDATTEL	—
DANIEL M TODD	—

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Pharmacy PHA

Prescription drug payment reform. Supply chain. Strategic National Stockpile.

Lobbyist	Covered position, as disclosed
PAUL EDATTEL	—
DANIEL M TODD	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.